Soligenix
SNGX
#10217
Rank
โ‚น1.47 B
Marketcap
โ‚น145.96
Share price
2.85%
Change (1 day)
-50.60%
Change (1 year)

Revenue for Soligenix (SNGX)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of โ‚น10.03 Million a decrease over the revenue in the year 2023 that were of โ‚น21.4 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Soligenix from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 โ‚น10.03 M-53.11%
2023 โ‚น21.4 M3.49%
2022 โ‚น20.68 M733.38%
2021 โ‚น2.48 M-98.24%
2020 โ‚น0.14 B-38.43%
2019 โ‚น0.22 B-17.3%
2018 โ‚น0.27 B0.47%
2017 โ‚น0.27 B-61.13%
2016 โ‚น0.71 B21.85%
2015 โ‚น0.58 B30.54%
2014 โ‚น0.44 B124.1%
2013 โ‚น0.19 B15.69%
2012 โ‚น0.17 B-57.53%
2011 โ‚น0.40 B364.48%
2010 โ‚น87.27 M-33.21%
2009 โ‚น0.13 B17.67%
2008 โ‚น0.11 B124.85%
2007 โ‚น49.38 M-51.79%
2006 โ‚น0.10 B-23.5%
2005 โ‚น0.13 B
1999 โ‚น0 M-100%
1998 โ‚น17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cleveland BioLabs
CBLI
โ‚น56.75 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น67.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.268 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚น5.639 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.277 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น7.18 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น20.3 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.506 TN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel